^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Small Intestinal Carcinoma |
| Drug: | gemcitabine (DNA synthesis inhibitor) + paclitaxel (Bcl2 inhibitor, Tubulin polymerization promoter) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Small Bowel Adenocarcinoma: Advanced or metastatic therapy regimens…Gemcitabine + paclitaxel
